DIA Biosimilars 2013

Articles Published in 2007

Quintiles Cuts Ribbon On New Research Facility

Friday, May 25, 2007 12:30 PM

North Carolina-based CRO Quintiles has opened a new four-story, 236,000-square-foot clinical research facility in Overland Park, Kan. The facility will replace the company’s Clinical Development Services and Clinical Pharmacology units located in Kansas City, Mo., as well a an early phase unit in Lenexa, Kan. The new phase I facility will be three times the space, consisting of 150 beds and room for up to 200 more staff. Quintiles already employs about 750 employees in the Kansas City area.

More... »

Cenduit: Now with Patient Reminders

Innovex Signs Agreement With ForceLogix For Sales Coaching Software

Friday, May 25, 2007 07:37 AM

Innovex, the Quintiles unit that provides commercialization services to the pharmaceutical, biotechnology and medical device industries, signed an agreement with software company ForceLogix to provide on-demand global access to Innsight, Innovex's custom-designed sales coaching tool.

More... »

CRF Health – eCOA Forum

CenterWatch Monthly: May 2007 Issue

Wednesday, May 23, 2007 10:40 AM

U.S. Sites Rate Novo Nordisk, Novartis and Roche as Top Sponsors in 2007

More... »

John Cline Resigns from etrials

Monday, May 21, 2007 05:15 PM

Morrisville, N.C.-based eClinical company etrials reported that John Cline, founder and long time chief executive officer of the company, has resigned his post effective immediately in order to pursue other "entrepreneurial endeavors." He will, however, remain a member of the board of directors.

More... »

Top Stories for the Week of May 14th 2007

Wednesday, May 16, 2007 05:22 PM

Top News

More... »

Senate Okays PDUFA

Friday, May 11, 2007 02:15 PM

In a 93-to-1 vote, the U.S. Senate has approved a bill re-authorizing the U.S. Food and Drug Administration (FDA) to collect fees from drug companies to review investigational new drugs. The bill would also require that all phase II and later stage trials for both drugs and devices be listed on the government’s web site, www.clinicaltrials.gov.

More... »

Top Stories for the Week of May 7th 2007

Wednesday, May 9, 2007 10:20 AM

Top News

More... »

PharmaNet On The Road To Recovery

Tuesday, May 8, 2007 10:05 AM

Princeton, N.J.-based PharmaNet Development Group reported first quarter revenue of $84.8 million compared with $74.4 million in the first quarter of 2006, a 13.9% increase. Total revenue, after out-of-pocket expenses, reached $107 million for the period.

More... »

Striving For Diversity In Clinical Trials

Wednesday, May 2, 2007 12:51 PM

AstraZeneca has launched a new initiative to address the lack of diversity in U.S. clinical trial participants. The big pharma company will provide significant grants to the National Medical Association (NMA), which represents more than 30,000 African American physicians, and the Interamerican College of Physicians and Surgeons (ICPS), a network of more than 39,000 physicians throughout the U.S. and Puerto Rico.

More... »

Top Stories for the Week of April 30th 2007

Monday, April 30, 2007 02:12 PM

Top News

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs